These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10829930)

  • 21. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
    al Saedi S; Dean H; Dent W; Stockl E; Cronin C
    Pediatrics; 1996 Jan; 97(1):100-2. PubMed ID: 8545200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
    Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
    Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of blood spot 17 alpha-hydroxyprogesterone concentration in neonates.
    Shimozawa K; Matsumoto M; Okada K; Murata M; Tsuchiya Y; Kitagawa T
    Horm Res; 1988; 30(6):246-51. PubMed ID: 3266938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal screening for congenital adrenal hyperplasia using 17-hydroxyprogesterone assay in filter paper blood spots.
    Larsson A; Hagenfeldt L; von Döbeln U; Curstedt T; Gustafsson J; Svensson E
    Horm Res; 1988; 30(6):235-40. PubMed ID: 3250925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
    de Hora MR; Heather NL; Webster D; Albert BB; Hofman PL
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3390-e3399. PubMed ID: 34058748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia.
    Hayashi G; Faure C; Brondi MF; Vallejos C; Soares D; Oliveira E; Brito VN; Mendonca BB; Bachega TA
    Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):632-7. PubMed ID: 22218447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns.
    Yoon YA; Woo S; Kim MS; Kim B; Choi YJ
    Exp Clin Endocrinol Diabetes; 2023 Apr; 131(4):216-221. PubMed ID: 36854385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X; Zhou J; Ye J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 17-hydroxiprogesterone values in healthy preterm infants.
    Mendoza-Rojas VC; Díaz-Martínez LA; Mantilla-Mora G; Contreras-García GA; Mora-Bautista VM; Martínez-Paredes JF; Calderón-Rojas AL; Gómez-Tarazona CA; Pinzón-Mantilla K
    Colomb Med (Cali); 2017 Dec; 48(4):161-166. PubMed ID: 29662257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
    BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for elevated levels of 17-hydroxyprogesterone during neonatal intensive care unit admission.
    Pauwels G; Allegaert K; Régal L; Meulemans A
    Acta Clin Belg; 2012; 67(2):88-93. PubMed ID: 22712163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
    Tsuji A; Konishi K; Hasegawa S; Anazawa A; Onishi T; Ono M; Morio T; Kitagawa T; Kashimada K
    BMC Pediatr; 2015 Dec; 15():209. PubMed ID: 26671474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basal 17-hydroxyprogesterone cannot accurately predict nonclassical congenital adrenal hyperplasia in children and adolescents.
    Bello R; Lebenthal Y; Lazar L; Shalitin S; Tenenbaum A; Phillip M; de Vries L
    Acta Paediatr; 2017 Jan; 106(1):155-160. PubMed ID: 27743484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of blood spot 17 alpha-hydroxyprogesterone concentration in premature infants--proposal for cut-off limits in screening for congenital adrenal hyperplasia.
    Ohkubo S; Shimozawa K; Matsumoto M; Kitagawa T
    Acta Paediatr Jpn; 1992 Apr; 34(2):126-33. PubMed ID: 1621517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
    Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
    Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortisol assay in dried blood spots to reduce false positive rate in congenital adrenal hyperplasia screening.
    Brossaud J; Barat P; Fagour L; Corcuff JB
    Clin Chim Acta; 2012 Aug; 413(15-16):1306-7. PubMed ID: 22561187
    [No Abstract]   [Full Text] [Related]  

  • 40. Longitudinal measurements of 17alpha-hydroxyprogesterone in premature infants during the first three months of life.
    Linder N; Davidovitch N; Kogan A; Barzilai A; Kuint J; Mazkeret R; Sack J
    Arch Dis Child Fetal Neonatal Ed; 1999 Nov; 81(3):F175-8. PubMed ID: 10525018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.